Recent studies have reported a correlation between ROR1 expression and poor clinical outcome including relapse and survival in ovarian cancer patients [18, 19] and have even linked ROR1 to ovarian cancer stem cell migration and growth of tumour xenografts [18, 19]. This evidence concerns the gene ROR1 and ovarian carcinoma.